Antisickling and sickling reversal activities of the polyphenol‑rich butanol fraction of Detarium microcarpum leaf extract and its putative bioactive molecules
This study demonstrates that the polyphenol-rich butanol fraction of *Detarium microcarpum* leaf extract is safe and exhibits significant sickling reversal activity in vitro, likely due to its high content of phenolics and flavonoids, suggesting its potential therapeutic application for managing sickle cell disease.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Sickle cell disease is a genetic condition that changes the shape of red blood cells, the tiny carriers that deliver oxygen throughout the body. In people with this condition, these cells can twist into a rigid, crescent shape when oxygen levels drop, much like a bean that has dried and curled. These misshapen cells get stuck in narrow blood vessels, causing severe pain and damaging organs, and they break down faster than normal cells, leading to chronic anemia. While modern medicine offers treatments to manage the crisis, many of these options are expensive or difficult to access, particularly in parts of Africa where the disease is most common. Because of this, scientists and communities have long looked to traditional plants for answers, hoping to find affordable, natural ways to stop these cells from deforming or to help them return to their normal shape once they have already twisted.
In a study focused on a tree known as sweet detar, researchers investigated whether its leaves could help manage this condition. The plant, which grows in the dry savannahs of West and Central Africa, has been used for generations in local folk medicine to treat various ailments, including blood disorders. The team, working in Nigeria, set out to test if the leaves could actually stop red blood cells from sickling or reverse the process if the cells had already changed shape. They began by collecting fresh leaves from the wild, drying them, and grinding them into a powder. This powder was soaked in alcohol to pull out the plant's chemical compounds, creating a crude extract. To understand which parts of the plant were doing the work, the researchers separated this extract into different groups based on how well they dissolved in various solvents, creating five distinct fractions ranging from those that held non-polar oils to those that held water-soluble substances.
Before testing the plant's effects on blood, the team first checked its safety. They gave high doses of the different plant extracts to mice to see if the substances were toxic. The results were reassuring: even at very high doses, the animals showed no signs of harm or behavioral changes, suggesting the plant material is safe to handle. The researchers then moved to the core experiment, using blood samples from adults in Nigeria who had been confirmed to have sickle cell disease. They took the red blood cells from these donors and placed them in a laboratory setting where they could be exposed to low oxygen conditions, which normally trigger the cells to sickle. The team tested the plant extracts to see if they could prevent the cells from twisting in the first place, and also if they could coax already twisted cells back into their round, healthy shape.
The experiments revealed that the plant extract was indeed active, but the power was not spread evenly across all the parts. When the researchers tested the different fractions, they found that the one containing the most water-soluble compounds, known as the butanol fraction, was the most effective. This specific fraction demonstrated a significant ability to reverse the sickling of 70% of the red blood cells in the test tubes. In contrast, the other fractions, which contained oils and other non-polar substances, did not show a significant ability to fix the twisted cells compared to a plain saltwater control. The study also looked at how quickly the plant worked. The butanol fraction acted rapidly, showing strong results within thirty minutes and maintaining that effect for up to two hours. Interestingly, the researchers found that using more of the extract did not necessarily make it work better; a lower concentration was just as effective as a higher one, suggesting that the specific chemical makeup of the plant matters more than the sheer amount used.
To understand what was inside the powerful butanol fraction, the scientists used a sophisticated machine called a mass spectrometer to identify the specific molecules present. They found a rich collection of natural compounds, particularly a group called polyphenols, which are known for their antioxidant properties. The analysis pointed to the presence of several specific types of molecules, including flavonoids and phenolic glycosides. One of the identified compounds was a type of sugar-linked molecule called a phenolic glycoside, and another was a flavonoid known as quercetin 3-galactoside. These are the same types of chemicals found in many fruits and vegetables that are known to protect cells from damage. The researchers also found traces of triterpenes, which are compounds often associated with reducing inflammation. While the study did not isolate a single pure chemical to prove it was the sole hero, the combination of these compounds in the butanol fraction appears to be responsible for the observed ability to straighten out the sickled cells.
The study concludes that the sweet detar leaf contains natural chemicals capable of reversing the sickling of red blood cells in a laboratory setting. The findings support the traditional use of this plant in managing blood disorders and suggest that the active ingredients are concentrated in the water-soluble parts of the leaf. However, the researchers are careful to note that these results come from test tubes and do not yet prove that the plant works the same way inside a human body. The next steps would involve testing the plant in living animals to see if it is safe and effective in a complex biological system, and eventually, if it could be developed into a standardized treatment. For now, the work provides a scientific foundation for a traditional remedy, identifying the specific chemical profile that makes the sweet detar leaf a promising candidate for future medical research.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.